Michael F. Mahoney
director
medical devices and diagnostics
Baxter
Italy
Biography
Michael F. Mahoney, age 51, has served as a director of Baxter since October 2015. Mahoney is chairman, president and chief executive officer at Boston Scientific Corporation and a member of the company’s board of directors. He first joined Boston Scientific in 2011, with a 24-year track record of building market-leading medical device, capital equipment and healthcare IT businesses. Prior to joining Boston Scientific, Mahoney served as worldwide chairman of Johnson & Johnson medical devices and diagnostics division and served as worldwide group chairman of Johnson & Johnson’s DePuy orthopedics and neuro-science business. He was president and chief executive officer of the Global Healthcare Exchange, a leading supply chain solutions company, from 2001 to 2007 before joining Johnson & Johnson. Earlier in his career, he advanced through a series of leadership roles at General Electric Medical Systems. He serves as a director of AdvaMed and is a member of the American Heart Association CEO Roundtable. Michael F. Mahoney, age 51, has served as a director of Baxter since October 2015. Mahoney is chairman, president and chief executive officer at Boston Scientific Corporation and a member of the company’s board of directors. He first joined Boston Scientific in 2011, with a 24-year track record of building market-leading medical device, capital equipment and healthcare IT businesses. Prior to joining Boston Scientific, Mahoney served as worldwide chairman of Johnson & Johnson medical devices and diagnostics division and served as worldwide group chairman of Johnson & Johnson’s DePuy orthopedics and neuro-science business. He was president and chief executive officer of the Global Healthcare Exchange, a leading supply chain solutions company, from 2001 to 2007 before joining Johnson & Johnson. Earlier in his career, he advanced through a series of leadership roles at General Electric Medical Systems. He serves as a director of AdvaMed and is a member of the American Heart Association CEO Roundtable.
Research Interest
market-leading medical device, capital equipment and healthcare IT businesses
